PPPaul J. Phelan

Paul J. Phelan

*This is an algorithmically generated author record based on publicly available information.

Paul J. Phelan has a total of 78 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Kidneys role in liver transplantation

    by D. U. S. Ratnapala, R. Dissanayake, P. Phelan

    Renal dysfunction in the forms of acute kidney injury and chronic kidney disease is common in patients with chronic liver cell disease with a negative impact on post liver transplant patient survival. Post liver transplantation chronic kidney disease is also a frequently encountered complication associated with adverse allograft and patient survival. Hence, early and precise measurement of renal function is pivotal in pre and post liver transplantation. Nonetheless, the existing methods of renal function evaluation have pros and cons, hence yet to establish complete authority. This review aims at exploring the precise methodology of evaluating renal function in liver disease, the impact and preventive strategies for pre LT AKI, CKD and post LT CKD.

  • Open Access

    Conquering immunological barrier- part 2: paired kidney exchange transplantation

    by D. U. S. Ratnapala, D. Pugh, P. Phelan

    ABO blood group or human leucocyte antigen (HLA) incompatibility remain major immunological barriers for organ transplantation. One strategic approach to conquer this barrier is desensitize the recipient yet it remains expensive, resource intensive with a higher risk of complications. Paired kidney exchange(PKE) is an alternative strategy, where an exchange of kidneys happens among pairs consisting of a recipient with a willing live donor, yet unmatched for the particular recipient, making transplant unfeasible. PKE has evolved in to many complex types since its introduction of concept in 1986. This review aims at discussing the types, global trends, challenges and ethical aspects of PKE transplantation.

  • High grade urothelial carcinoma in kidney transplant patients with a history of BK viremia – Just a coincidence?

    by Emma Cannon, Chara Ntala, Nicola Joss, Maeve Rahilly, Wendy Metcalfe, Marie O'DOnnell, Paul J Phelan

    Introduction: Kidney transplant recipients (KTR) have a three‐to‐four‐fold increased risk of developing urothelial carcinoma (UC) compared to the general population. BK polyoma virus (BKV) infection is known to affect approximately 15% of KTR. In vitro models support a potential pathogenic role for BKV in the development of UC. We describe a series of UC in kidney transplant recipients.Methods: Electronic patient records were searched to identify KTR with UC who had undergone kidney only or simultaneous kidney and pancreas transplantation in a single UK center between 2009 and 2015. Where available, stored pathological samples were retrieved, re‐examined and stained for SV40 as a marker of BKV using standard staining protocols for kidney biopsy samples.Results: Fourteen KTR had developed UC post‐transplant. Of these, 10 KTR had a history of BKV infection post‐transplant. Six of these 10 KTR developed a rare micropapillary tumor subtype of UC which is typically only found in <1% of UC cases. All six micropapillary tumor samples stained positive for SV40, including samples from metastases. Three tumor samples were available from the four KTR with no history of BKV infection and were not micropapillary subtype and were negative for SV40. Three micropapillary tumors from immunocompetent patients were examined as controls and were negative for SV40.Conclusions: These findings would support a pathogenic role for BK virus in the development of rare micropapillary subtype urothelial tumors in the kidney transplant population.


  • Comparison of kidney transplant outcomes in HLA compatible and incompatible transplantation: A national cohort study

    by Trijntje J. W. Rennie, Richard K. Battle, Angela A. Abel, Sylvia McConnell, Robert McLaren, Paul J. Phelan, Colin Geddes, Neal Padmanabhan, Marc J. Clancy, Ann‐Margaret Little, et al.

    Background: Reports of HLA incompatible (HLAi) kidney transplant outcomes are inconclusive, especially in the context of lower level Donor Specific Antibodies (DSA).Methods: Multi‐centre national cohort study of HLAi kidney transplant recipients matched in 1:2 ratio with HLA compatible (HLAc) kidney transplant recipients. HLAi defined as DSA identified by Luminex. Antibody mediated rejection (AMR) and transplant‐survival were analysed using Kaplan–Meier plots. Propensity score (PS) matching was used to compare recipient and transplant survival between groups.Results: We included 61 HLAi and 122 HLAc recipients; mean age 46 years; 60% female. MFIT0: 3327 (IQR 1352–6458), 23 (38%) were Flow cytometry crossmatch positive (FC‐XMPOS). DSAPOS/FC‐XMPOS transplantation carried an increased risk of AMR at 1 year (52%) compared to DSAPOS/FC‐XMNEG (27%) and HLAc (0%). Unadjusted death censored graft loss at 3 years was 13% (HLAi) and 8% (HLAc). Three‐year patient survival was 95% in HLAc, 84% in DSAPOS/FC‐XMNEG and 69% in DSAPOS/FC‐XMPOS recipients; 58% of HLAi deaths were infection‐related. HLA incompatibility was associated with a decreased 3‐year survival in our PS‐matched cohort.Conclusion: In kidney transplantation, DSA and positive FC‐XM carries an increased risk of AMR. Despite inferior transplant and survival outcomes compared to HLAc transplantation, it remains a realistic option for highly sensitized patients facing prolonged waiting times and reduced survival on dialysis.


  • Efficacy and side effect profile of two CMV prophylaxis strategies in high and intermediate risk kidney transplant recipients – a multicentre national study

    by Trijntje J. W. Rennie, Colin G. Geddes, Rhianna McIntyre-McClure, Bernadine H. E. Chua, Wendy Metcalfe, Ingólfur Johannessen, Paul J. Phelan


  • Open Access

    Acute renal transplant dysfunction in a living donor kidney transplant recipient

    by Stephen O’nEill, Stuart Falconer, Andrew I. Sutherland, Paul J. Phelan

  • Open Access

    Long- and short-term outcomes in renal allografts with deceased donors: A large recipient and donor genome-wide association study

    by Maria P. Hernandez-Fuentes, Christopher Franklin, Irene Rebollo-Mesa, Jennifer Mollon, Florence Delaney, Esperanza Perucha, Caragh Stapleton, Richard Borrows, Catherine Byrne, Gianpiero Cavalleri, et al.


  • Open Access

    Twitter-Based Journal Clubs: Additional Facts and Clarifications

    by Joel M Topf, Matthew A Sparks, Francesco Iannuzzella, Edgar Lerma, Thomas Oates, Paul J Phelan, Swapnil Hiremath

    We read the recently published paper on globalization of continuing professional development by Roberts et al with great interest. The authors should be congratulated on their idea as well as their execution of this novel way of evaluating and describing Twitter-based journal clubs. We would like to add to their article by providing some additional advantages and features of a Twitter-based online journal club to provide the reader with a more complete appreciation of their educational potential.


  • Open Access

    13C-n.m.r. of the cyanylated β-lactoglobulins: evidence that Cys-121 provides the thiol group of β-lactoglobulins A and B

    by P Phelan, J P Malthouse

    The thiol groups of beta-lactoglobulins A and B have been cyanylated using [13C]KCN. The samples of [cyanato-13C]-cyanylated-beta-lactoglobulins A and B which we prepared had signals at 109.7 p.p.m. and 114.4 p.p.m. We conclude that the thiocyanate carbon having a chemical shift of 109.7 p.p.m. is in an apolar environment similar to a cyclohexane solvent, whereas the thiocyanate carbon having a chemical shift of 114.4 p.p.m. is in a polar environment similar to water. The signals with chemical shifts of 109.7 p.p.m. are assigned to the thiocyanate carbons of the native [cyanato-13C]cyanylated-beta-lactoglobulins A and B. We deduce that the signal at 114.4 p.p.m. is due to an irreversibly denatured/unfolded species produced by alkaline denaturation, which is caused by intramolecular thiol/disulphide exchange occurring during our cyanylation procedure. We propose that Cys-119 is cyanylated in the irreversibly denatured species and Cys-121 is cyanylated in the native [cyanato-13C]cyanylated-beta-lactoglobulins A and B. We suggest that the same intramolecular thiol-disulphide exchange reactions occurred when McKenzie and co-workers [McKenzie, Ralston and Shaw (1972) Biochemistry 11, 4539-4547] alkylated beta-lactoglobulins with iodoacetamide. Therefore the one mol of thiol/mol of monomer in the native beta-lactoglobulins is due to the thiol of Cys-121 and is not due to an equimolar mixture of Cys-119 and Cys-121 as they suggested.